Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566228 · ClinicalTrials.gov registry record · Phase 3
Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma
A Phase 3 study of Lymphoma, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 122
- Enrollment target
- 1
- Study location
NCT00566228 is a Phase 3 study of Lymphoma that has completed, run by Mayo Clinic. The registered enrollment target is 122 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00566228, a Phase 3 study of Lymphoma, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant. PURPOSE: This randomized phase III trial is comparing two different methods of collecting stem cells in patients undergoing stem cell transplant for diffuse large cell lymphoma.
Conditions Studied
Interventions
- PROCEDURE autologous hematopoietic stem cell transplantation
- PROCEDURE leukapheresis
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2007-12 |
| Est. Completion | 2015-01-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00566228
The ClinicalTrials.gov registry entry for NCT00566228 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (75% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which autologous hematopoietic stem cell transplantation is the first listed.
NCT00566228 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00566228 about?
NCT00566228 is a clinical study titled "Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma". RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant. PURPOSE: This randomized phase III trial is comparing two different methods of collecting stem cells in patients undergoing stem cell transplant for diffuse large ...
What is the current status of trial NCT00566228?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 122 participants. The study started on 2007-12. Estimated completion is 2015-01-15.
What conditions does trial NCT00566228 study?
This clinical trial studies the following conditions: Lymphoma.
What interventions are being tested in trial NCT00566228?
The interventions under investigation include: autologous hematopoietic stem cell transplantation (PROCEDURE), leukapheresis (PROCEDURE).
Who is sponsoring clinical trial NCT00566228?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00566228 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RECRUITING · Phase 3
-
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
ACTIVE NOT RECRUITING · Phase 3
-
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
ACTIVE NOT RECRUITING · Phase 3
-
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.